chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. On 09-MAY-2014, the patients were vaccinated with doses of VARIVAX (Merck) (lot # H020250 exp date 06-NOV-2014 also reported as 08-NOV-2014) (dose not reported) subcutaneously that were improperly exposed to 7 degree C from 15-MAY-2013 to 09-MAY-2014. No known adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected. All follow ups requested to complete the case were received.
pt recv vax & w/in 18hr pt devel an inj site rxn characterized by redness, swelling & induration;also exp body aches & flu like sx which caused pt to miss 1 day of work;
Pt recvd 1st dose of vax on 24JUL92 & approx 4-5 hrs p/receiving vax & exp flu-like synd characterized by pharyngitis, h/a, sweating, arthralgia, myalgia & fatigue; felt flush, neck stiffness & back pain;
Just a couple of minutes after the COVID-19 vaccine, my whole face and tongue started tingling and was a strange  numbing feeling throughout my face. It started getting better after about 30 minutes. However, the left side near my jaw felt numb through the evening and my tongue was still tingly feeling. Today (the day after the vaccine) my tongue feels more like a burn. Worried about taking the 2nd dose after such a strange feeling  from this first dose.
I woke up in the morning and could not lift my arms above my head, I was in a lot of pain. I had to bring my head to the table to eat, I was extremely fatigued, I was taking naps. My PCP was not really addressing any of this she kept telling me to take Tylenol. I was finally able to get in to see a Rheumatologist who complete blood panel. My inflammation levels were extremely high and I had to take Prednisone for two years but he was able to find that I have Polymyalgia Rheumatica.
My ankle started to show adverse reaction being a bubbly rash that was leaking yellow liquids the day after my vaccine that went up my calf, bumps began to form all over my body on the next day, blisters and boils started to form between fingers and toes after the next day followed by itchiness and pain. Upon getting my second dose, September 20th, 2021. it began to cause my body to bring uncontrollable itchiness, and all symptoms began to become extremely unbearable, ears were leaking yellow liquid, and almost everything except my genital region was reacting. These symptoms have left scarring all over my body. Diagnosed with psoriatic arthritis and Psoriasis, Lost most use of right knee and right eye is completely blind, 14% functionality in the left eye. It is keeping me awake every day causing me to go on many prescriptions and topical creams that are not helping at all.
1/12/07 Left leg swelling on Saturday 1/18/07 started vomiting ER visit on 1/14 meds given for vomiting. Left leg swelling vomiting reducing.
11/15/10 received flu injection Rt delt. about 24 hours later 11/16 Rt arm became very sensitive - painful to touch - was seen in ER - put on Ibuprofen - told to elevate arm 11/17 was seen by another facility - tx IB & elevation.
Close to 24 hours after my vaccine I started  to have goosebumps and then chills. Soon after the severe tiredness kicked in along with a cough. Then I started running a fever. I was hot with chills and when I wasn?t under a blanket I was shaking uncontrollably. I took ibuprofen which helped a little. Ended up taking an Ativan to sleep. The next morning I felt like I had the flu. Still feverish with a deep cough. Groggy, lethargic and tired. Took a two hour nap around 4. Starting to feel better but I?m exhausted and very irritable.
Received DTaP number 2, Comvax #2, IPV #2 and Prevnar #2 on 7/26/2004 in AM. On 7/28 pt went to our right clinic and presented with a rash on her left leg at the injections site with some raised erythema. Both extremities also had rash. No fever.
Received telephone call from pt's mom 11:20am on 01/28/04.  She states her son has puffy eyes and redness under both and around his cheeks.  No fever.  Complained of stomach ache.  Was informed by MD that this was a reaction from the flu vaccine.
This spontaneous report as received from a physician refers to a unspecified patients of unknown age and gender. The patient's medical history and current conditions were not provided. On an unknown dates, the patients were vaccinated with a doses of VARIVAX (Merck) (dose and route were not reported) lot # J005724 expiration date 08-MAY-2015 that were improperly stored. The temperature excursion for the VARIVAX (Merck) was found to be supported with in-house stability data. Secondary suspects and concomitant therapies were not reported. No adverse symptoms reported. Additional information has been requested. This is one of several reports received from the same reporter.
DIED; HEART RACING; HEADACHE; This spontaneous report received from a consumer via a company representative via social media concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. Per procedure, no follow-up will be requested for this case. On an unspecified date, the patient complained of heart racing and headache and the patient died two weeks later. The cause of death was unknown. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of unknown cause of death on an unspecified date, and the outcome of heart racing and headache was not reported. This report was serious (Death).; Sender's Comments: V0 20210835168-COVID-19 VACCINE AD26.COV2.S-died. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
INJECTED 1ST DOSE PFIZER AND SECOND DOSE MODERNA 21 DAYS APART.
pt recv vax; T 102; body & aching joints,lasted 2 wk, n & v; inject site swollen, hot x 1 wk;
pt recv vax 420PM & w/in 5-10min mom noted rash (hive-like) @ face & gradually over 1hr scattered eruptions @ trunk & extremities;given DPH;pulse ox 96% @ 435PM & 99% @ 515PM;VS stable;
Immediately after giving MMR child turned pale on lips, periorally and on his face.  Did not pass out.  Lasted for approximately 30-45 seconds.  No posturing or loss of consciousness.
no adverse effects; a patient was administered an expired dose of MMR II; This spontaneous report was received from a nurse, via company representative, referring to a 13 month old patient.  No information was provided regarding the patient's medical history, concurrent conditions or drug reactions/allergies.  Concomitant therapies included sterile diluent.      On 05-AUG-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (dose, dose nu,number, route and site of administration were not reported).     The vaccine administered was lot # N020927 and had expired on 01-AUG-2019.     It was reported that the patient received all other vaccines that were routine for a 12 month old child.  No adverse event.
pain in arm; fever of 102.6 degrees Fahrenheit; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), PYREXIA (fever of 102.6 degrees Fahrenheit), CHILLS (chills) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in arm), PYREXIA (fever of 102.6 degrees Fahrenheit), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (pain in arm), PYREXIA (fever of 102.6 degrees Fahrenheit), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
lo grade fever 1st 24 hrs; arm swelling started + or - 24 hrs; p/vax erythema of arm began +/- 48 hrs p/hospital admission advised when erythema involved entire upper arm elbow to shoulder;
Extreme rash on arms, stomach, lower back and moderate rash on face.  lasted two weeksThe booster
Severe joint pain.  Continued  Pain radiating to side of neck (vaccine side) left.  Lower back pain.  Confusion, lethargic.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: patient had tingling in the left arm
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was aching/ sore), PERIPHERAL SWELLING (Swollen), ASTHENIA (Weakness), BACK PAIN (Her upper back is in pain) and PALPITATIONS (Her heart was racing) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 26-Mar-2020.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was aching/ sore) and PERIPHERAL SWELLING (Swollen). On 15-Mar-2021, the patient experienced ASTHENIA (Weakness), FATIGUE (Began experiencing fatigue), HEADACHE (Headaches) and ARTHRALGIA (Her joints hurt). On 22-Mar-2021, the patient experienced BACK PAIN (Her upper back is in pain) and PALPITATIONS (Her heart was racing). The patient was treated with PARACETAMOL (TYLENOL) (oral) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) (oral) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm was aching/ sore), PERIPHERAL SWELLING (Swollen), ASTHENIA (Weakness), BACK PAIN (Her upper back is in pain), PALPITATIONS (Her heart was racing), FATIGUE (Began experiencing fatigue), HEADACHE (Headaches) and ARTHRALGIA (Her joints hurt) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Ended up with Adenocarcinoma In Situ due to the HPV 18 strain (found out bout the diagnosis in sept 2018 approx). Had part of my cervix removed in May 2019 by Dr. Margins came back negative (no more cancer was found)
The afternoon of receiving vax, pt was running temperature and was quiet. Mother called Health Department to report. Pt was given Tylenol at 12:30 PM. Pt broke out in chicken pox later that night.
Patient got the Moderna vaccine on Monday in the morning. The next morning , the patient started to experience redness and swelling at the injection site of the vaccine. Patient commented that the vaccinator gave the vaccine at a lower site that what is recommended for the vaccine. The injection was given lower on the arm and closer to the elbow instead of the lower deltoid. The swelling has gone down two days after the vaccine was given. The patient still has a red mark at where the injection was given. She also complains of itching at where the vaccine was given.
nausea, headache, strong pressure in ears, lightheaded, weak, sore joints (knees, hands), face turned red, breathing change (SOB, asthma triggered), sore Left UE, rash on left ankle.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Jan2022 as dose 3 (booster),single (Batch/Lot number: unknown) at the age of 36 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "PCOS" (unspecified if ongoing); "Insulin Resistant" (unspecified if ongoing), notes: other medical history:Insulin Resistant; "known allergies: Pencillin" (unspecified if ongoing), notes: known allergies: Pencillin. Concomitant medication(s) included: METFORMIN; LEXAPRO. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient keep getting large red welts, similar to bug bites, sporadically since getting the second dose of the Covid vaccine; Patient keep getting large red welts, similar to bug bites, sporadically since getting the second dose of the Covid vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: VACCINATION SITE URTICARIA (non-serious), VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown" and all described as "Patient keep getting large red welts, similar to bug bites, sporadically since getting the second dose of the Covid vaccine".  Clinical Course: Patient keep getting large red welts, similar to bug bites, sporadically since getting the second dose of the Covid vaccine. They are not like a typical rash and are not from bugs or any environmental changes. he was wondering if there was any other reports of this. Forwarded as an Adverse Event by the team on 14Mar2022 Reporter provided verification of contact address on 13Mar2022.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Stroke ~ 15 hours after 2d Pfizer injection.  911 Ambulance to the medical center
Report A0361508A describes injection site cellulitis in a 4 year old male who received Infanrix. Medical history, concurrent conditions, and concurrent medications were not specified. On an unspecified date, the vaccinee received an injection of Infanrix; it was not known if he had received previous injections of Infanrix. Subsequently, he experienced cellulitis at the injection site. He was seen in the clinic and unspecified medication was prescribed. As of 2/11/2002; the outcome of the event was unknown.
No adverse reaction reported.   Patient was supposed to have been given Pentacel but instead only received the DTaP-IPV component.  Patient will be brought back in for single dose of Hib.  Pentacel was wasted and reported.  DTaP and IPV were listed historically for patient.
metallic taste in my mouth late last night and this morning; Aches; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in my mouth late last night and this morning), PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced DYSGEUSIA (metallic taste in my mouth late last night and this morning), PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, DYSGEUSIA (metallic taste in my mouth late last night and this morning), PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No concomitant medications were mentioned. No treatment details were reported.   This case was linked to MOD-2021-364243 (Patient Link).
Patient hasn't reported any adverse effects. We mistakenly gave a gray cap Pfizer vaccine at 29 hours after draw up time. We called Pfizer and they told us there was a 24 hour excursion period. We were past that at 29 hours. We called the CDC and they recommended we give another vaccine immediately. We called the patient and he is coming back tonight for another vaccine.  How this happened is that the vaccine only had the time on the vial not the date. It said 9:28 AM and we thought that was today but later determined it was from yesterday.
several days p/vax pt exp blotchy rash on face, rpt pt not feeling well & exp malaise. 10/12/98 pt saw MD & dx w/herpes zoster. pt had vesicular eruption, significant rt arm pain, cannot move arm. treated w/zovirax, motrin, pramasone.
This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown date the unspecified number of patients were vaccinated with improperly stored doses of ROTATEQ oral (dose, dose number, lot number and expiration date were unspecified). Concomitant therapies were not reported. No adverse symptoms reported. This is one of several reports received from the same reporter. Additional information has been requested.
C/O dizziness with 3 minutes after injection.  O2Sat 93%, BP 150/80, HR 80, BS 121.  Pt states did not eat today.  Given water and crackers.  Dizziness subsided within 20 min.
After receiving both doses of the vaccine (first dose at 6pm on 3/30 and second does at 6pm on 4/22  and a full night?s sleep, I woke up, walked to the bathroom, and passed out. I was unconscious for a minute and was helped up, but then collapsed again for another minute. Emergency medical services were contacted both times.
Information has been received from a registered nurse concerning a patient who "in the past" was vaccinated with a pediatric/adolescent (0.5 ml) dose of RECOMBIVAX HB. Recently the titer was checked and found to be low. It was unknown if the patient sought medical attention. At the time of the report, the outcome of the patient was unknown. Additional information has been requested.
Information has been received from a 82 female with sulfa allergy and antifungal drugs allergy who on 30-DEC-2008 was vaccinated SQ with 0.65 ml of ZOSTAVAX (Merck) (lot number: 663176/1554X) at 11:00 a.m. Concomitant therapy included vitamins (unspecified) and calcium (unspecified). The patient reported that on 15-MAR-2009 that she developed shingles after getting the vaccine. The patient also reported that her shingles were not painful and she was not developing blisters yet. The patient was not recovered and did not seek medical attention. Follow-up information was received. The reporter stated that the patient's herpes zoster was confirmed at a dermatologist's office. The outcome for the patient's herpes zoster was reported as recovered on 06-APR-2009. Additional information is not expected.
Client presented for 2nd dose in Moderna monovalent primary series and received expired vaccine. After administration of vaccine client sat 15 mins. in waiting area for observation of side effects. Non noted. Expiration of the vaccine was not noted until 2:00 pm after clinic closed. Vaccine expired 04/01/2023. Client was contacted and informed of the incident,denied any side effects and potential for revaccination. Moderna was contacted to check viability of expired vaccine. See below #19. Based on response from Moderna's analysts revaccination is not needed. client made aware.
A report has been received from a Pharmacist concerning a 54 year old, male subject, who had been receiving FLUMIST. FLUMIST started on 22-Nov-2013. They accidentally gave FLUMIST to a 54 year old patient on 22-Nov-2013. The outcome of the event of accidentally gave FLUMIST to a 54 year old patient is unknown. The report was considered to be non-serious.
101  temperature,  nausea, vomiting, body aches, chills, muscle aches, body sweats,  diarrhea,  headaches  all day on Feb 4th
Caller reports arm soreness after both doses of the vaccine; The initial case was missing the following minimum criteria no adverse effect. Upon receipt of 25Aug2021 case contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer or other non hcp (patient) via medical information team. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on Mar2021 (batch or lot number was not reported) as dose 2, single dose for covid-19 immunisation. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on Feb2021 (batch or lot number was not reported) as dose 1, single dose for covid-19 immunisation and experienced her arm was little bit sore. The patient's medical history and concomitant medications were not reported. On unspecified date in 2021, the patient experienced arm soreness after both doses (arm was little bit sore after each dose) of the vaccine. Patient did not had any side effects. She had her arm was a little sore and also she stated any time she get a shot it like that. Patient inquired regarding does that present any health problems, having it that close together regards to the booster or 3rd dose of the Pfizer COVID vaccination. Patient would like to know efficacy data that we may have on the vaccine. Patient received both doses of the Pfizer covid 19 vaccinations. First dose in Feb2021 and the second dose was had in Mar2021. Patient inquired regarding the booster dose. She would like to know when she can get the booster doses and questions 6 to 8 months after the 2nd dose and also stated booster shot for Pfizer and that was in Feb and Mar and she asked how long did she have to wait and they told her to get one within a month after the last shot and also stated called earlier just to see when she can get and she think it was on 18th that she called. After that patient stated that she can get a booster one month after the last shot, after the last vaccine so, that answered her question then she got a letter saying that her question was unclear so, did they give her wrong answer or that's the right answer. That's bother if they gave her the wrong answer. Caller didn't know she did mention that her arm was little bit sore after each dose but that is not why she called but she got her first dose in Feb2021 and her second dose is in Mar2021 but she did not have the specific dates. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was found unresponsive on 10/26/22 and brought to the hospital. She tested positive for COVID on 10/26/22. She remained in the hospital and admitted to hospice. She passed away on 11/10/22.